Skip to main content
Top
Published in: Brain Tumor Pathology 4/2017

01-10-2017 | Rapid Short Communication

Downregulation of SMARCB1/INI1 expression in pediatric chordomas correlates with upregulation of miR-671-5p and miR-193a-5p expressions

Authors: Prit Benny Malgulwar, Pankaj Pathak, Manmohan Singh, Shashank Sharad Kale, Vaishali Suri, Chitra Sarkar, Mehar Chand Sharma

Published in: Brain Tumor Pathology | Issue 4/2017

Login to get access

Abstract

Loss of SMARCB1/INI1 expression is considered to be a hallmark for childhood chordomas (CCs). Although mutation/loss of 22q has strongly established the loss of SMARCB1/INI1 in cancers, the cause in CCs remains elusive. Recent studies suggest role of miRNAs in regulation of SMARCB1/INI1 expressions. We examined 5 reported/target predicted miRNAs to SMARCB1/INI1 in SMARCB1/INI1 immunonegative and immunopositive cases, and found upregulation of miR-671-5p and miR-193a-5p in SMARCB1/INI1-immunonegative cases. Notably, these two miRNAs were significantly predicted to target TGF-β signaling, suggestive of dysregulation of developmental and osteoblast regulation pathway in CCs. Overall, we suggest miR-671-5p- and miR-193a-5p-mediated epigenetic mode of SMARCB1/INI1 loss and downregulated TGF-β pathway in CCs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mobley BC, McKenney JK, Bangs CD et al (2010) Loss of SMARCB1/INI1 expression in poorly differentiated chordomas. Acta Neuropathol 120:745–753CrossRefPubMed Mobley BC, McKenney JK, Bangs CD et al (2010) Loss of SMARCB1/INI1 expression in poorly differentiated chordomas. Acta Neuropathol 120:745–753CrossRefPubMed
2.
go back to reference Ridenour RV 3rd, Ahrens WA, Folpe AL et al (2010) Clinical and histopathologic features of chordomas in children and young adults. Pediatr Dev Pathol 13:9–17CrossRefPubMed Ridenour RV 3rd, Ahrens WA, Folpe AL et al (2010) Clinical and histopathologic features of chordomas in children and young adults. Pediatr Dev Pathol 13:9–17CrossRefPubMed
3.
go back to reference Yadav R, Sharma MC, Malgulwar PB et al (2014) Prognostic value of MIB-1, p53, epidermal growth factor receptor, and INI1 in childhood chordomas. Neuro Oncol 16:372–381CrossRefPubMed Yadav R, Sharma MC, Malgulwar PB et al (2014) Prognostic value of MIB-1, p53, epidermal growth factor receptor, and INI1 in childhood chordomas. Neuro Oncol 16:372–381CrossRefPubMed
4.
go back to reference Djuranovic S, Nahvi A, Green R (2012) miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 336:237–240CrossRefPubMedPubMedCentral Djuranovic S, Nahvi A, Green R (2012) miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 336:237–240CrossRefPubMedPubMedCentral
5.
go back to reference Nakano H, Yamada Y, Miyazawa T et al (2013) Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells. Int J Oncol 42:1875–1882CrossRefPubMedPubMedCentral Nakano H, Yamada Y, Miyazawa T et al (2013) Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells. Int J Oncol 42:1875–1882CrossRefPubMedPubMedCentral
7.
go back to reference Jones MF, Hara T, Francis P et al (2015) The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation. Proc Natl Acad Sci USA 112:E1550–E1558CrossRefPubMedPubMedCentral Jones MF, Hara T, Francis P et al (2015) The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation. Proc Natl Acad Sci USA 112:E1550–E1558CrossRefPubMedPubMedCentral
8.
go back to reference Papp G, Krausz T, Stricker TP et al (2014) SMARCB1 expression in epithelioid sarcoma is regulated by miR-206, miR-381, and miR-671-5p on both mRNA and protein levels. Genes Chromosomes Cancer 53:168–176CrossRefPubMed Papp G, Krausz T, Stricker TP et al (2014) SMARCB1 expression in epithelioid sarcoma is regulated by miR-206, miR-381, and miR-671-5p on both mRNA and protein levels. Genes Chromosomes Cancer 53:168–176CrossRefPubMed
9.
go back to reference Kohashi K, Yamamoto H, Kumagai R et al (2014) Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression. Mod Pathol 27:832–839CrossRefPubMed Kohashi K, Yamamoto H, Kumagai R et al (2014) Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression. Mod Pathol 27:832–839CrossRefPubMed
10.
go back to reference Sápi Z, Papp G, Szendrői M et al (2016) Epigenetic regulation of SMARCB1 By miR-206, -381 and -671-5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR-765 appears specific for epithelioid sarcoma. A miRNA study of 223 soft tissue sarcomas. Genes Chromosomes Cancer 55:786–802CrossRefPubMed Sápi Z, Papp G, Szendrői M et al (2016) Epigenetic regulation of SMARCB1 By miR-206, -381 and -671-5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR-765 appears specific for epithelioid sarcoma. A miRNA study of 223 soft tissue sarcomas. Genes Chromosomes Cancer 55:786–802CrossRefPubMed
11.
go back to reference Sharma V, Purkait S, Takkar S et al (2016) Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors. Brain Tumor Pathol 33:117–128CrossRefPubMed Sharma V, Purkait S, Takkar S et al (2016) Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors. Brain Tumor Pathol 33:117–128CrossRefPubMed
12.
go back to reference Venneti S, Le P, Martinez D et al (2011) p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors. J Neuropathol Exp Neurol 70:596–609CrossRefPubMedPubMedCentral Venneti S, Le P, Martinez D et al (2011) p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors. J Neuropathol Exp Neurol 70:596–609CrossRefPubMedPubMedCentral
13.
14.
go back to reference Papp G, Changchien YC, Péterfia B et al (2013) SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma. Mod Pathol 26:393–403CrossRefPubMed Papp G, Changchien YC, Péterfia B et al (2013) SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma. Mod Pathol 26:393–403CrossRefPubMed
16.
go back to reference Jeibmann A, Schulz J, Eikmeier K et al (2017) SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors. J Neurooncol 131:477–484CrossRefPubMed Jeibmann A, Schulz J, Eikmeier K et al (2017) SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors. J Neurooncol 131:477–484CrossRefPubMed
17.
go back to reference Sun H, Zhong X, Wang C et al (2016) SNF5 is involved in suppression of hepatocellular carcinoma progression via TGF-Beta 1 signaling. Anat Rec (Hoboken) 299:869–877CrossRef Sun H, Zhong X, Wang C et al (2016) SNF5 is involved in suppression of hepatocellular carcinoma progression via TGF-Beta 1 signaling. Anat Rec (Hoboken) 299:869–877CrossRef
18.
go back to reference Gold LI (1999) The role for transforming growth factor-beta (TGF-beta) in human cancer. Crit Rev Oncog 10:303–360PubMed Gold LI (1999) The role for transforming growth factor-beta (TGF-beta) in human cancer. Crit Rev Oncog 10:303–360PubMed
19.
go back to reference Joseph JV, Balasubramaniyan V, Walenkamp A et al (2013) TGF-β as a therapeutic target in high grade gliomas—promises and challenges. Biochem Pharmacol 85:478–485CrossRefPubMed Joseph JV, Balasubramaniyan V, Walenkamp A et al (2013) TGF-β as a therapeutic target in high grade gliomas—promises and challenges. Biochem Pharmacol 85:478–485CrossRefPubMed
Metadata
Title
Downregulation of SMARCB1/INI1 expression in pediatric chordomas correlates with upregulation of miR-671-5p and miR-193a-5p expressions
Authors
Prit Benny Malgulwar
Pankaj Pathak
Manmohan Singh
Shashank Sharad Kale
Vaishali Suri
Chitra Sarkar
Mehar Chand Sharma
Publication date
01-10-2017
Publisher
Springer Singapore
Published in
Brain Tumor Pathology / Issue 4/2017
Print ISSN: 1433-7398
Electronic ISSN: 1861-387X
DOI
https://doi.org/10.1007/s10014-017-0295-7

Other articles of this Issue 4/2017

Brain Tumor Pathology 4/2017 Go to the issue